Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-Dose Exposure Study of FlutiForm in Asthma
NCT00830102Phase 2Completed
- Sponsor
- Skyepharma
- Start
- Oct 2004
- Primary completion
- Jan 2005
- Modality
- Orthosteric Ligands
- Countries
- 2
01
Overview
A Phase 2 trial of fluticasone propionate + formoterol in asthma, sponsored by Skyepharma. Started Oct 2004; status: completed.
02
Drugs
fluticasone propionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00830102.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00830102.